A regularly prescribed class of heart medications might be capable of treating one of the most common forms of muscular dystrophy, a new study in mice suggests. Myotonic dystrophy type 1 (DM1) is caused by abnormal RNA that affects the function of calcium channel receptors, which help convert impulses from nerve cells into chemical signals that guide muscle movement, the researchers explained. Given that, a type of heart drug called a calcium channel blocker might be able to eliminate the "noise" caused by this abnormal RNA, they reasoned. These drugs successfully eased DM1 symptoms in lab mice bred to have...